Drug Shortage Report for OXALIPLATIN
Report ID | 4033 |
Drug Identification Number | 02444763 |
Brand name | OXALIPLATIN |
Common or Proper name | OXALIPLATIN |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | OXALIPLATIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10ML VIAL / FLACON |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-04-13 |
Actual start date | |
Estimated end date | 2017-06-20 |
Actual end date | 2017-06-20 |
Shortage status | Resolved |
Updated date | 2017-06-21 |
Company comments | Please note that other formats: 100mg/ 20 mL and 200mg/ 40 mL vials are available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2017-06-21 | English | Compare |
v8 | 2017-06-20 | French | Compare |
v7 | 2017-06-20 | English | Compare |
v6 | 2017-04-14 | English | Compare |
v5 | 2017-04-13 | French | Compare |
v4 | 2017-04-13 | English | Compare |
v3 | 2017-04-08 | English | Compare |
v2 | 2017-03-23 | French | Compare |
v1 | 2017-03-23 | English | Compare |
Showing 1 to 9 of 9